Preclinical Validation of a Novel Drug Lead to Treat Tuberculosis (2018–2023)

Grant type:
United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
  • Professor
    Frazer Institute
    Faculty of Medicine
  • Professorial Research Fellow - GL
    Institute for Molecular Bioscience
    Affiliate Professorial Res Fellow
    School of Chemistry and Molecular Biosciences
    Faculty of Science
  • NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
Funded by:
United States Department of Defense